Find your path to Gary
215 people in our graph share verified history with Gary — schools, employers, funds. One of them is your warm intro.
Christiana BardonunlockedGary: together at Mpmcapital (2005–2007)
Gary: together at Mpmcapital
Gary: together at City of London School
×8Gary: together at MPM BioImpact
About
Gary Patou is a Senior Clinical Advisor at Patou Management Consulting with experience spanning clinical development, pharmaceuticals, and investment. He has led drug development programs across multiple therapeutic areas including infectious disease, pain, dermatology, autoimmune disease, and vaccines, contributing to five drug approvals and achieving primary endpoints in 12 of 13 Phase 3 trials. His background includes work in both large pharmaceutical and biotech settings, with expertise in small molecule and biologic development.
Executive at Star Therapeutics
Intro paths
→
In turn, Gary can intro founders to Star Therapeutics's investors below.
Star Therapeutics's investors · 15
Agent CapitalWaltham · since 2025Blue Owl CapitalNew York · since 2025Catalio Capital ManagementNew York · since 2025Cowen Healthcare InvestmentsNew York · since 2025Frazier Life SciencesPalo Alto · since 2025Janus Henderson InvestorsLondon · since 2025New Leaf Venture PartnersNew York · since 2025NYBC VenturesNew York · since 2025OrbiMedNew York · $1M – $75M checks · since 2025RA CapitalBoston · since 2025REDMILESan Francisco · since 2025Sanofi VenturesCambridge · $5M checks · since 2025Sofinnova VenturesMenlo Park · $100K – $15M checks · since 2025Viking Global InvestorsStamford · since 2025Westlake Village BioPartnersLos Angeles · $100K – $5M checks · since 2025
Co-founders at Star Therapeutics
AR
Adam RosenthalFounder & CEO
NS
Nancy StaglianoDirector
Experience
- Patou Management ConsultingSenior Clinical Advisorcurrent2020 — presentUnited States
- Xenon Pharmaceuticals Inc.Board Membercurrent2004 — presentGreater Vancouver Metropolitan Area
- Vega TherapeuticsChief Medical Officer2020 — 2026United States
- Star TherapeuticsChief Medical Officer2020 — 2026United States
- Electra TherapeuticsChief Medical Officer2020 — 2024United States
- MPM CapitalAdvisor2020 — 2022San Francisco Bay Area
- MPM CapitalManaging Director2005 — 2020
- Blade TherapeuticsChief Medical Officer2018 — 2020
- ChiasmaHead of Clinical2014 — 2020
- True North TherapeuticsChief Medical Officer2016 — 2017
- Bioverativ, a Sanofi companySenior Clinical Consultant2017
- Pacira Pharmaceuticals, Inc.Chief Medical Officer2009 — 2015
- Peplin LtdChief Medical Officer2006 — 2008
- Genesoft Pharmaceuticals/Oscient PharmaceuticalsPresident and Chief Medical Officer2001 — 2005
- GlaxoSmithKlineSenior Vice President, Drug Development Projects1998 — 2000
- GlaxoSmithKlineVice President, Anti-infectives1995 — 1998
Skills & more
StrategyBoard LevelNew Drug Application (NDA)Company buildingVenture CapitalBiotechnologyCorporate DevelopmentStart-upsPrivate EquityPharmaceutical DevelopmentClinical ResearchClinical Development
+11 more
TurnaroundsCompany TurnaroundLife SciencesLifesciencesClinical TrialsDue DiligenceProduct DevelopmentDrug DiscoveryBiopharmaceuticalsMedical DevicesTurn Around ManagementFrom Gary's professional profile.
Deals · 1
BioInterveneBoard seat
via MPM BioImpact · filed Mar 2019 · $3.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
Network4
Ansbert K. Gadicke
Managing Partner at MPM BioImpact
Bard Geesaman
Managing Partner at MPM Capital
Briggs Morrison
Entrepreneur Partner at MPM BioImpact
Dan Hicklin
Managing Partner at MPM Capital
Investors connected to Gary in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Gary Patou?
- Gary Patou is a Senior Clinical Advisor at Patou Management Consulting with experience spanning clinical development, pharmaceuticals, and investment. He has led drug development programs across multiple therapeutic areas including infectious disease, pain, dermatology, autoimmune disease, and vaccines, contributing to five drug approvals and achieving primary endpoints in 12 of 13 Phase 3 trials. His background includes work in both large pharmaceutical and biotech settings, with expertise in small molecule and biologic development.
- Where does Gary Patou work?
- Gary Patou is Executive at Star Therapeutics.
- What boards does Gary Patou sit on?
- Gary Patou holds tracked board seats at BioIntervene.
- Where did Gary Patou go to school?
- Gary Patou studied at Royal College of Pathology (Fellow of the Royal College of Pathologists (FRCPath)); Faculty of Pharmaceutical Medicine (Member of Faculty Pharmaceutical Medince (MFPM)); Faculty of Pharmaceutical Medicine (Diploma in Pharmaceutical Medicine).
Same school
Also attended Faculty of Pharmaceutical Medicine2
Also attended UCL706
Demis HassabisCo-founder & CEO of Google DeepMindAndré DuboisInvestor at Index VenturesFrédérique DameInvestor at GV (Google Ventures)Jonas VetterleInvestor at Moonfire VenturesMarie FerriInvestor at DaphniElena PantaziPartner & Head of Platform at Northzone
+ 700 more
Also attended City of London School13
Reid JacksonInvestor at Luminar VenturesTim LevenePartner and CEO at Augmentum FintechAndrew WaidhoferPartner at Apax DigitalPaul BotjePrincipal at Greencode VenturesAdam GrossmanPartner at Amulet Capital Partners, LPCameron ChweidanInvestor at ASK Partners
+ 7 more
Shared employers
Also worked at Chiasma5
Also worked at True North Therapeutics2
Also worked at Bioverativ, a Sanofi company1
Also worked at Pacira Pharmaceuticals, Inc.9
Ryan KrausVice President at 1315 CapitalScott BraunsteinVice-Chairman of the Board and Director at atai Life SciencesMarcelo BigalVenture Partner at Versant VenturesGerald MaccioliChief Medical Officer at AdentrisRanice BrownFounder at Magier AIJason GallagherChief Commercial Officer/Chief Operations Officer at Spine BioPharma
+ 3 more